Buy Xefra tablet 400 mg 30’s Online At Best Price In Pakistan

Dosage

Missed Dose

Take the missed dose as soon as you remember. If it is almost time for the next scheduled dose, then the missed dose can be skipped. Do not use extra medicine to make up for the missed dose.

Overdose

Seek emergency medical treatment or contact the doctor in case of an overdose.

Interactions

Dexamethasone   (severe)

Heparin   (severe)

Celecoxib   (severe)

Amlodipine   (moderate)

Albendazole   (moderate)

Cisplatin   (severe)

Gentamicin   (severe)

Estradiol   (moderate)

Prednisone   (severe)

Paracetamol   (severe)

Atorvastatin   (moderate)

Aspirin   (severe)

Abciximab   (severe)

Balsalazide   (severe)

Antacids containing aluminum   (moderate)

Prescribes

Iron overload

This medicine is used to treat an excessive amount of iron accumulated in the body due to repeated blood transfusions.

Non-transfusion dependent thalassemia (NTDT)

This medicine is used to treat an excessive amount of iron accumulated in the body due to a genetic blood disorder called non-transfusion-dependent thalassemia.

Side Effects

Nausea and vomiting  

Dizziness  

Earache  

Stomach pain  

Loss of vision or blurred vision   (severe)

Hearing impairment   (severe)

Black or tarry stools   (severe)

Bleeding gums   (severe)

Unusual tiredness or weakness   (severe)

Puffing or swelling of eyelids   (severe)

Unusual bleeding or bruising   (severe)

Fever  

Cough or hoarseness  

Respiratory tract infection   (severe)

Abnormal blood counts   (severe)

Warnings

Other medicines

Pediatric use

Clinical monitoring

Form based dosing

Liver diseases

Kidney diseases

Use in elderly

Severe allergic reaction

Gastrointestinal disorders

Pregnancy

Breast-feeding

When Not To Use

Allergy

This medicine is not recommended for use in patients with a known allergy to Xefra tablet 400 mg 30’s or any other inactive ingredients present in the formulation.

Poor performance status

This medicine is not recommended for use in patients with poor performance status, which is an indicator of the ability to perform certain activities of daily living without the help of others. These activities include getting dressed, eating, working a regular job, etc.

Myelodysplastic syndrome

This medicine is not recommended for use in patients with high-risk myelodysplastic syndromes, a group of disorders characterized by the inability of the bone marrow to produce healthy blood cells.

Advanced malignancies

This medicine is not recommended for use in patients suffering from advanced or end-stage cancers.

Low platelet count

This medicine is not recommended for use in patients with very low blood platelet counts (less than 50,000/mm3) due to the increased risk of worsening of the patient's condition.

Severe renal impairment

This medicine is not recommended for use in patients with a severe impairment of kidney function (creatinine clearance less than 40 ml/min) due to the increased risk of serious adverse effects.

Severe liver impairment

This medicine is not recommended for use in patients with a severe impairment of liver function (Child-Pugh Category C) due to the increased risk of serious adverse effects.